Outcomes
The outcomes assessed were DXA-based HSA indices for the NN, IT, and FS at baseline (before treatment initiation); weeks 12, 24, 48, and 78; and the last visit, and CT-based HSA indices at baseline and week 78 for the ABL and PBO groups. The mean percent changes from baseline for each parameter were also compared between the treatment groups.